• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比较所选抗生素对多杀性巴氏杆菌和鼠伤寒沙门氏菌动物分离株的最小抑菌浓度和突变预防浓度。

Comparing the minimum inhibitory and mutant prevention concentrations of selected antibiotics against animal isolates of Pasteurella multocida and Salmonella typhimurium.

机构信息

Hans Hoheisen Research Station, Faculty of Veterinary Science, University of Pretoria, Pretoria, South Africa; and, Department of Veterinary Tropical Disease, Faculty of Veterinary Science, University of Pretoria, Pretoria.

出版信息

Onderstepoort J Vet Res. 2022 Jan 10;89(1):e1-e7. doi: 10.4102/ojvr.v89i1.1955.

DOI:10.4102/ojvr.v89i1.1955
PMID:35144445
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8831991/
Abstract

Historically, the use of antibiotics was not well regulated in veterinary medicine. The emergence of antibiotic resistance (ABR) in pathogenic bacteria in human and veterinary medicine has driven the need for greater antibiotic stewardship. The preservation of certain antibiotic classes for use exclusively in humans, especially in cases of multidrug resistance, has highlighted the need for veterinarians to reduce its use and redefine dosage regimens of antibiotics to ensure efficacy and guard against the development of ABR pathogens. The minimum inhibitory concentration (MIC), the lowest concentration of an antibiotic drug that will prevent the growth of a bacterium, is recognised as a method to assist in antibiotic dosage determination. Minimum inhibitory concentrations sometimes fail to deal with first-step mutants in bacterial populations; therefore dosing regimens based solely on MIC can lead to the development of ABR. The mutant prevention concentration (MPC) is the minimum inhibitory antibiotic concentration of the most resistant first-step mutant. Mutant prevention concentration determination as a complementary and sometimes preferable alternative to MIC determination for veterinarians when managing bacterial pathogens. The results of this study focused on livestock pathogens and antibiotics used to treat them, which had a MIC value of 0.25 µg/mL for enrofloxacin against all 27 isolates of Salmonella typhimurium. The MPC values were 0.50 µg/mL, with the exception of five isolates that had MPC values of 4.00 µg/mL. The MPC test yielded 65.52% (18 isolates) Salmonella isolates with florfenicol MICs in the sensitive range, while 11 isolates were in the resistant range. Seventeen isolates (58.62%) of Pasteurella multocida had MIC values in the susceptible range and 41.38% (12 isolates) had an intermediate MIC value. Mutant prevention concentration determinations as done in this study is effective for the antibiotic treatment of bacterial infections and minimising the development of resistance. The MPC method can be used to better control to prevent the development of antibiotic drug resistance used in animals.

摘要

从历史上看,兽医领域对抗生素的使用并未得到很好的监管。人用和兽用医学中病原菌对抗生素耐药性(ABR)的出现,推动了对抗生素更严格管理的需求。为了在人类中专门保留某些抗生素类别,特别是在多药耐药的情况下,兽医需要减少抗生素的使用并重新定义抗生素剂量方案,以确保疗效并防止 ABR 病原体的出现。最低抑菌浓度(MIC)是指能够阻止细菌生长的最低抗生素药物浓度,被认为是一种辅助确定抗生素剂量的方法。最低抑菌浓度有时无法应对细菌群体中的第一步突变体;因此,仅基于 MIC 的剂量方案可能导致 ABR 的发展。突变预防浓度(MPC)是最耐药的第一步突变体的最低抑菌抗生素浓度。在管理细菌病原体时,突变预防浓度的测定是兽医替代 MIC 测定的一种补充方法,有时也是首选方法。本研究的结果集中在用于治疗牲畜病原体的抗生素上,恩诺沙星对所有 27 株鼠伤寒沙门氏菌的 MIC 值为 0.25 µg/mL。除了五个 MPC 值为 4.00 µg/mL 的分离株外,MPC 值为 0.50 µg/mL。MPC 试验产生了 65.52%(18 株)具有氟苯尼考 MIC 值处于敏感范围的沙门氏菌分离株,而 11 株处于耐药范围。17 株(58.62%)多杀巴斯德氏菌分离株的 MIC 值处于敏感范围,41.38%(12 株)的 MIC 值处于中介范围。本研究中进行的突变预防浓度测定可有效用于治疗细菌感染和减少耐药性的发展。MPC 方法可用于更好地控制动物中抗生素的使用,以防止抗生素耐药性的发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1229/8831991/db329db10b16/OJVR-89-1955-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1229/8831991/db329db10b16/OJVR-89-1955-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1229/8831991/db329db10b16/OJVR-89-1955-g001.jpg

相似文献

1
Comparing the minimum inhibitory and mutant prevention concentrations of selected antibiotics against animal isolates of Pasteurella multocida and Salmonella typhimurium.比较所选抗生素对多杀性巴氏杆菌和鼠伤寒沙门氏菌动物分离株的最小抑菌浓度和突变预防浓度。
Onderstepoort J Vet Res. 2022 Jan 10;89(1):e1-e7. doi: 10.4102/ojvr.v89i1.1955.
2
Mutant prevention and minimum inhibitory concentration drug values for enrofloxacin, ceftiofur, florfenicol, tilmicosin and tulathromycin tested against swine pathogens Actinobacillus pleuropneumoniae, Pasteurella multocida and Streptococcus suis.检测抗猪病原体胸膜肺炎放线杆菌、多杀巴斯德菌和猪链球菌的恩诺沙星、头孢噻呋、氟苯尼考、替米考星和泰乐菌素的突变预防和最小抑菌浓度药物值。
PLoS One. 2019 Jan 10;14(1):e0210154. doi: 10.1371/journal.pone.0210154. eCollection 2019.
3
Concentration-resistance relationship and PK/PD evaluation of danofloxacin against emergence of resistant Pasteurella multocida in an in vitro dynamic model.丹氟沙星对体外动态模型中耐药多杀巴斯德菌出现的浓度耐药关系及 PK/PD 评价。
J Appl Microbiol. 2024 Jul 2;135(7). doi: 10.1093/jambio/lxae154.
4
Mutant prevention concentration of ciprofloxacin and enrofloxacin against Escherichia coli, Salmonella Typhimurium and Pseudomonas aeruginosa.环丙沙星和恩诺沙星对大肠杆菌、鼠伤寒沙门氏菌和铜绿假单胞菌的突变预防浓度。
Vet Microbiol. 2007 Jan 31;119(2-4):304-10. doi: 10.1016/j.vetmic.2006.08.018. Epub 2006 Aug 17.
5
The phenotypic and molecular resistance induced by a single-exposure to sub-mutant prevention concentration of marbofloxacin in Salmonella Typhimurium isolates from swine.单次暴露于低于突变预防浓度的马波沙星后,猪源鼠伤寒沙门氏菌分离株诱导产生的表型和分子抗性。
Vet Microbiol. 2017 Aug;207:29-35. doi: 10.1016/j.vetmic.2017.05.026. Epub 2017 Jun 1.
6
Reduced Susceptibility of Typhimurium Strains to Oregano Essential Oil and Enrofloxacin: An Assay.肠炎沙门氏菌对牛至精油和恩诺沙星敏感性降低:一种测定方法。
Foodborne Pathog Dis. 2020 Jan;17(1):29-34. doi: 10.1089/fpd.2019.2635. Epub 2019 Nov 11.
7
Potency of marbofloxacin for pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida: Comparison of growth media.马波沙星对猪肺炎病原体胸膜肺炎放线杆菌和多杀性巴氏杆菌的抗菌效力:生长培养基的比较
Res Vet Sci. 2017 Apr;111:43-48. doi: 10.1016/j.rvsc.2016.11.001. Epub 2016 Nov 25.
8
Activity of florfenicol for Actinobacillus pleuropneumoniae and Pasteurella multocida using standardised versus non-standardised methodology.使用标准化与非标准化方法测定氟苯尼考对胸膜肺炎放线杆菌和多杀性巴氏杆菌的活性。
Vet J. 2016 Dec;218:65-70. doi: 10.1016/j.tvjl.2016.11.004. Epub 2016 Nov 16.
9
Mutant prevention concentration and PK-PD relationships of enrofloxacin for Pasteurella multocida in buffalo calves.恩诺沙星对水牛犊巴氏杆菌的突变预防浓度和 PK-PD 关系。
Res Vet Sci. 2013 Dec;95(3):1114-24. doi: 10.1016/j.rvsc.2013.07.019. Epub 2013 Aug 12.
10
Comparative mutant prevention concentration and mechanism of resistance to veterinary fluoroquinolones in Staphylococcus pseudintermedius.中间型葡萄球菌对兽用氟喹诺酮类药物的比较突变预防浓度及耐药机制
Vet Dermatol. 2012 Aug;23(4):376-80, e68-9. doi: 10.1111/j.1365-3164.2012.01038.x. Epub 2012 Mar 12.

引用本文的文献

1
Mutant Prevention Concentration, Frequency of Spontaneous Mutant Selection, and Mutant Selection Window-a New Approach to the Determination of the Antimicrobial Potency of Compounds.突变预防浓度、自发突变选择频率和突变选择窗——一种新的确定化合物抗菌效力的方法。
Antimicrob Agents Chemother. 2023 May 17;67(5):e0137322. doi: 10.1128/aac.01373-22. Epub 2023 Apr 6.
2
Enrofloxacin-The Ruthless Killer of Eukaryotic Cells or the Last Hope in the Fight against Bacterial Infections?恩诺沙星——真核细胞的无情杀手还是对抗细菌感染的最后希望?
Int J Mol Sci. 2022 Mar 26;23(7):3648. doi: 10.3390/ijms23073648.

本文引用的文献

1
Antibiotic use in food animals worldwide, with a focus on Africa: Pluses and minuses.全球范围内食品动物中的抗生素使用,重点关注非洲:利弊分析。
J Glob Antimicrob Resist. 2020 Mar;20:170-177. doi: 10.1016/j.jgar.2019.07.031. Epub 2019 Aug 8.
2
Variation in Mutant Prevention Concentrations.突变预防浓度的变化。
Front Microbiol. 2019 Jan 31;10:42. doi: 10.3389/fmicb.2019.00042. eCollection 2019.
3
Mutant prevention and minimum inhibitory concentration drug values for enrofloxacin, ceftiofur, florfenicol, tilmicosin and tulathromycin tested against swine pathogens Actinobacillus pleuropneumoniae, Pasteurella multocida and Streptococcus suis.
检测抗猪病原体胸膜肺炎放线杆菌、多杀巴斯德菌和猪链球菌的恩诺沙星、头孢噻呋、氟苯尼考、替米考星和泰乐菌素的突变预防和最小抑菌浓度药物值。
PLoS One. 2019 Jan 10;14(1):e0210154. doi: 10.1371/journal.pone.0210154. eCollection 2019.
4
Revisiting the mutant prevention concentration to guide dosing in childhood tuberculosis.重新审视突变预防浓度以指导儿童结核病的给药
J Antimicrob Chemother. 2017 Jul 1;72(7):1848-1857. doi: 10.1093/jac/dkx051.
5
Workshop report: the 2012 antimicrobial agents in veterinary medicine: exploring the consequences of antimicrobial drug use: a 3-D approach.研讨会报告:2012年兽用抗菌药物:探究抗菌药物使用的后果:一种三维方法
J Vet Pharmacol Ther. 2014 Feb;37(1):e1-e16. doi: 10.1111/jvp.12104. Epub 2014 Jan 6.
6
Bacterial resistance studies using in vitro dynamic models: the predictive power of the mutant prevention and minimum inhibitory antibiotic concentrations.使用体外动态模型进行细菌耐药性研究:突变预防浓度和最低抑菌抗生素浓度的预测能力。
Antimicrob Agents Chemother. 2013 Oct;57(10):4956-62. doi: 10.1128/AAC.00578-13. Epub 2013 Jul 29.
7
Mutant-prevention concentration and mechanism of resistance in clinical isolates and enrofloxacin/marbofloxacin-selected mutants of Escherichia coli of canine origin.犬源大肠杆菌临床分离株及其恩诺沙星/马波沙星选择突变株的抗突变浓度和耐药机制。
J Med Microbiol. 2011 Oct;60(Pt 10):1512-1522. doi: 10.1099/jmm.0.028654-0. Epub 2011 May 19.
8
MICs, MPCs and PK/PDs: a match (sometimes) made in hosts.最低抑菌浓度、防突变浓度与药代动力学/药效学:(有时)在宿主体内达成的匹配。
Expert Rev Respir Med. 2007 Aug;1(1):7-16. doi: 10.1586/17476348.1.1.7.
9
New concepts in antimicrobial susceptibility testing: the mutant prevention concentration and mutant selection window approach.抗菌药物敏感性试验的新概念:突变预防浓度和突变选择窗方法。
Vet Dermatol. 2009 Oct;20(5-6):383-96. doi: 10.1111/j.1365-3164.2009.00856.x.
10
Pharmacokinetics of the bovine formulation of enrofloxacin (Baytril 100) in horses.恩诺沙星牛用制剂(拜有利100)在马体内的药代动力学。
Vet Ther. 2001 Spring;2(2):129-34.